Juyeon Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juyeon Hwang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Hyun-Jin Kim
Cancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang-si, South Korea
4 shared publications - Kui Son Choi
National Cancer Control Institute, National Cancer Center, Goyang, South Korea
2 shared publications - Phillip Park
Affiliations Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology, Sung Kyun Kwan University, Seoul, Korea, Cancer Data Center, National Cancer Control Institute, National Cancer Center, Goyang, Korea
2 shared publications - Sun-Young Kong
Targeted Therapy Branch National Cancer Center Goyang Republic of Korea
2 shared publications - Ye-Lin Park
Affiliation Cancer Data Center, National Cancer Control Institute, National Cancer Center, Goyang, Korea
2 shared publications - Yeon Ho Choi
Cancer Data Center, National Cancer Control Institute, National Cancer Center, Goyang, Korea
2 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Vol. 9 (8)
Development of K-CORE: a web-based platform for integrated clinico-genomic analysis.
One of the key challenges in cancer treatment and precision oncology is the use of multi-omics data and their integration into matched clinical information. Although several analytical portals have been developed, most platforms do not support user-uploaded data or the integrated analysis of clinical and multi-omics datasets. To address these limitations, we developed the Korea Cancer Omics Research (K-CORE) portal, a user-friendly analytical platform designed to integrate and analyze multi-omics and clinical data. K-CORE supports various omics levels and a wide range of analytical tools. To validate the utility and reproducibility of the K-CORE, we designed synthetic datasets that reflected real-world omics data distributions. The analytical results from K-CORE were compared side by side with those from widely used R packages such as maftools and edgeR. In conclusion, K-CORE offers a practical and intuitive platform for the multidomain integration of clinical and omics data, supporting the advancement of precision oncology. Nevertheless, as analytical technologies and precision oncology continue to evolve, continuous maintenance and user feedback will become essential for future platform improvements.
- 22 May 2026
- Vol. 9 (8)
Open AccessDevelopment of K-CORE: a web-based platform for integrated clinico-genomic analysis.
One of the key challenges in cancer treatment and precision oncology is the use of multi-omics data and their integration into matched clinical information. Although several analytical portals have been developed, most platforms do not support user-uploaded data or the integrated analysis of clinical and multi-omics datasets. To address these limitations, we developed the Korea Cancer Omics Research (K-CORE) portal, a user-friendly analytical platform designed to integrate and analyze multi-omics and clinical data. K-CORE supports various omics levels and a wide range of analytical tools. To validate the utility and reproducibility of the K-CORE, we designed synthetic datasets that reflected real-world omics data distributions. The analytical results from K-CORE were compared side by side with those from widely used R packages such as maftools and edgeR. In conclusion, K-CORE offers a practical and intuitive platform for the multidomain integration of clinical and omics data, supporting the advancement of precision oncology. Nevertheless, as analytical technologies and precision oncology continue to evolve, continuous maintenance and user feedback will become essential for future platform improvements.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (8) , e79
Application of a Natural Language Processing Framework for Data Extraction From Pathology Reports Across Multiple Cancer Types
Park P, et al. J Korean Med Sci. 2026 Feb;41:e79. https://doi.org/10.3346/jkms.2026.41.e79
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (8) , e79
Open AccessApplication of a Natural Language Processing Framework for Data Extraction From Pathology Reports Across Multiple Cancer Types
Park P, et al. J Korean Med Sci. 2026 Feb;41:e79. https://doi.org/10.3346/jkms.2026.41.e79
- 21 December 2024
- Published by Elsevier in Chemosphere
- Vol. 370, 144002
Association between chronic ambient heavy metal exposure and mental health in Korean adult patients with asthma and the general population
- 21 December 2024
- Published by Elsevier in Chemosphere
- Vol. 370, 144002
Association between chronic ambient heavy metal exposure and mental health in Korean adult patients with asthma and the general population
- Open Access
Mortality Prediction Modeling for Patients with Breast Cancer Based on Explainable Machine Learning
Background/Objectives: Breast cancer is the most common cancer in women worldwide, requiring strategic efforts to reduce its mortality. This study aimed to develop a predictive classification model for breast cancer mortality using real-world data, including various clinical features. Methods: A total of 11,286 patients with breast cancer from the National Cancer Center were included in this study. The mortality rate of the total sample was approximately 6.2%. Propensity score matching was used to reduce bias. Several machine learning models, including extreme gradient boosting, were applied to 31 clinical features. To enhance model interpretability, we used the SHapley Additive exPlanations method. ML analyses were also performed on the samples, excluding patients who developed other cancers after breast cancer. Results: Among the ML models, the XGB model exhibited the highest discriminatory power, with an area under the curve of 0.8722 and a specificity of 0.9472. Key predictors of the mortality classification model included occurrence in other organs, age at diagnosis, N stage, T stage, curative radiation treatment, and Ki-67(%). Even after excluding patients who developed other cancers after breast cancer, the XGB model remained the best-performing, with an AUC of 0.8518 and a specificity of 0.9766. Additionally, the top predictors from SHAP were similar to the results for the overall sample. Conclusions: Our models provided excellent predictions of breast cancer mortality using real-world data from South Korea. Explainable artificial intelligence, such as SHAP, validated the clinical applicability and interpretability of these models.
Open AccessMortality Prediction Modeling for Patients with Breast Cancer Based on Explainable Machine Learning
Background/Objectives: Breast cancer is the most common cancer in women worldwide, requiring strategic efforts to reduce its mortality. This study aimed to develop a predictive classification model for breast cancer mortality using real-world data, including various clinical features. Methods: A total of 11,286 patients with breast cancer from the National Cancer Center were included in this study. The mortality rate of the total sample was approximately 6.2%. Propensity score matching was used to reduce bias. Several machine learning models, including extreme gradient boosting, were applied to 31 clinical features. To enhance model interpretability, we used the SHapley Additive exPlanations method. ML analyses were also performed on the samples, excluding patients who developed other cancers after breast cancer. Results: Among the ML models, the XGB model exhibited the highest discriminatory power, with an area under the curve of 0.8722 and a specificity of 0.9472. Key predictors of the mortality classification model included occurrence in other organs, age at diagnosis, N stage, T stage, curative radiation treatment, and Ki-67(%). Even after excluding patients who developed other cancers after breast cancer, the XGB model remained the best-performing, with an AUC of 0.8518 and a specificity of 0.9766. Additionally, the top predictors from SHAP were similar to the results for the overall sample. Conclusions: Our models provided excellent predictions of breast cancer mortality using real-world data from South Korea. Explainable artificial intelligence, such as SHAP, validated the clinical applicability and interpretability of these models.